Nicolas Alcala

Genomic Epidemiology Branch
Lyon, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications

Deep molecular profiling of lung neuroendocrine tumours and supra-carcinoids.

Deep molecular profiling of lung neuroendocrine tumours and supra-carcinoids.

Journal: Molecular cancer
Published: February 27, 2026

An Integrative RNA Spliceosomic Landscape of Pancreatic Neuroendocrine Tumors Identifies Clinically Relevant Molecular Subgroups.

An Integrative RNA Spliceosomic Landscape of Pancreatic Neuroendocrine Tumors Identifies Clinically Relevant Molecular Subgroups.

Journal: Endocrine pathology
Published: February 12, 2026

Moving Beyond Morphology: Toward a Morpho-Molecular Classification of Pleural Mesothelioma.

Moving Beyond Morphology: Toward a Morpho-Molecular Classification of Pleural Mesothelioma.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 17, 2025

A signature-agnostic test for differences between tumor mutation spectra reveals carcinogen and ancestry effects.

A signature-agnostic test for differences between tumor mutation spectra reveals carcinogen and ancestry effects.

Journal: Communications biology
Published: November 14, 2025

Autoencoders reveal polyunsaturated fatty acids (PUFA)-Related metabolic signature linked to cancer risk.

Autoencoders reveal polyunsaturated fatty acids (PUFA)-Related metabolic signature linked to cancer risk.

Journal: EBioMedicine
Published: July 25, 2025

The European Prospective Investigation into Cancer and Nutrition Cohort (EPIC): a gateway to rare cancer epidemiological research.

The European Prospective Investigation into Cancer and Nutrition Cohort (EPIC): a gateway to rare cancer epidemiological research.

Journal: ESMO rare cancers
Published: July 15, 2025

Novel concepts of cell-of origin in neuroendocrine neoplasms.

Novel concepts of cell-of origin in neuroendocrine neoplasms.

Journal: Virchows Archiv : an international journal of pathology
Published: June 06, 2025

A signature-agnostic test for differences between tumor mutation spectra reveals carcinogen and ancestry effects.

A signature-agnostic test for differences between tumor mutation spectra reveals carcinogen and ancestry effects.

Journal: bioRxiv : the preprint server for biology
Published: June 06, 2025

Basic science and translational implications of current knowledge on neuroendocrine tumors.

Basic science and translational implications of current knowledge on neuroendocrine tumors.

Journal: The Journal of clinical investigation
Published: March 03, 2025

A Response to the Letter to the Editor: "Linear Versus Non-Linear: Debunking Critiques on PCA Use in Molecular Subgrouping of Pulmonary Carcinoids".

A Response to the Letter to the Editor: "Linear Versus Non-Linear: Debunking Critiques on PCA Use in Molecular Subgrouping of Pulmonary Carcinoids".

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: January 12, 2025

ONECUT2 reprograms neuroendocrine fate and is an actionable therapeutic target in small cell lung cancer.

ONECUT2 reprograms neuroendocrine fate and is an actionable therapeutic target in small cell lung cancer.

Journal: Molecular medicine (Cambridge, Mass.)
Published: January 08, 2025

TERT Expression and Clinical Outcome in Pulmonary Carcinoids.

TERT Expression and Clinical Outcome in Pulmonary Carcinoids.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 30, 2024
Showing 1-12 of 30

Last Updated: 09/26/2026